The road to optimal hemostasis:

The Road to Optimal Hemostasis:
Avoiding Misadventures in Bleeding & Thrombosis
Bibliography

Braunwald E, Antman EM, Beasley JW, et al, for the American College of Cardiology;
American Heart Association. ACC/AHA 2002 guideline update for the management of
patients with unstable angina and non-ST-segment elevation myocardial infarction—
summary article: a report of the American College of Cardiology/American Heart
Association task force on practice guidelines (Committee on the Management of Patients
With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-1374.
Disorders of hemostasis. In: Harrison’s Internal Medicine. New York, NY: Mc-Graw
Hill; 2007. Available at: http://www.
accessmedicine.com/resourceToc.aspx?resourceID=4. Accessed January 4, 2008.
Ferraris VA, Ferraris SP, Saha SP, et al, for the Society of Thoracic Surgeons Blood
Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special
Task Force on Blood Transfusion. Perioperative blood transfusion and blood
conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of
Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg.
2007;83:S27–S86.
Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice
guideline series: aspirin and other antiplatelet agents during operative coronary
revascularization (executive summary). Ann Thorac Surg. 2005;79:1454-1461.
Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM Jr. Aspirin and postoperative
bleeding after coronary artery bypass grafting. Ann Surg. 2002;235:820-827.
Fitzgerald DJ, Maree A. Aspirin and clopidogrel resistance. Hematology Am Soc Hematol
Educ Program. 2007;1:114-120.
Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factors IX and
X on the surface of activated platelets: thoughts on the mechanism of action of high-dose
activated factor VII. Blood Coag Fibrinol. 1998;9(suppl 1):S61-S65.
Hongo RH, Ley J, Dick SE, Yee RR. The effect of clopidogrel in combination with
aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol.
2002;40:231-237.
Levy JH, Hursting MJ. Heparin-induced thrombocytopenia, a prothrombotic disease.
Hematol Oncol Clin North Am. 2007;21:65-88.
Levy JH, Tanaka KA, Hursting MJ. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Anesth Analg. 2007;105:570-582. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma. 2006;60(6 suppl):S46-S50. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007;49:1362-1368. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol. 2005;45:1157-1164. Plavix (clopidogrel bisulfate) [package insert]. Bridgewater, NJ: Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; 2007. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev. 1999;13:177-186. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion. 2004;44:1143-1148. Wiviott SD, Antman EM. Clopidogrel resistance. A new chapter in a fast-moving story. Circulation. 2004;109:3064-3067. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med. 2001;29:2271-2275.

Source: http://www.bloodcmecenter.org/Downloads/Rd_Opt_Hemo_Ref.pdf